TAMMIE MOORE: Open Payments
NPI 1447515515 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 56 payments from 17 companies in 2025. Trend: 2023 $86 · 2024 $403 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $264 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $178 |
| Phathom Pharmaceuticals, Inc. | 11 | $143 |
| GENZYME CORPORATION | 4 | $112 |
| Janssen Biotech, Inc. | 4 | $81 |
| Lilly USA, LLC | 3 | $67 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Ardelyx, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
Products named: XIFAXAN, VOQUEZNA, DUPIXENT, ENTYVIO, TREMFYA, OMVOH, ZENPEP, IBSRELA.
Industry payments across DE — which companies pay providers there.
